OYE Therapeutics

Invest in OYE - invest in the future 

OYE anticipates completing a near term clinical development and regulatory milestone upon receipt of the full readout of our Phase II human clinical study Q3/2024. 

Value Proposition

​"Open Your Eyes" is traditionally the first instruction you hear upon waking from general anesthesia following a medical procedure. OYE is making that safer for the patient and the medical professional. Our mission is to save lives by filling gaps in care that have been overlooked. 

Hear the story about the product that launched the company >

Image of military personnel in the build

OYE invited to participate in ACTTION Conference February, 2024

OYE Therapeutics, Inc. to Participate at ACTTION Consortium Meeting Co-Chaired by Dr. Ken Solt, the Director of Translational Research and Innovation in Anesthesia Critical Care and Pain Medicine at Harvard Medical School

​Convened by Dr. Solt, the meeting aims to bring together a diverse group of experts, spanning anesthesiology, neurology, and consciousness research. The goal is to foster collaborative discussions and initiatives that will drive innovation in anesthetic agents and modulation.
Image of military personnel in the build

BIO (Biotechnology Innovation Organization) Investor Forum                  October, 2023